SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001933414-23-000012
Filing Date
2023-03-15
Accepted
2023-03-15 17:17:07
Documents
21
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mlys2022123110k.htm 10-K 1483517
2 EX-4.3 mlys2022123110kex43.htm EX-4.3 21234
3 EX-23.1 mlys2022123110kex231.htm EX-23.1 2456
4 EX-31.1 mlys2022123110kex311.htm EX-31.1 10177
5 EX-31.2 mlys2022123110kex312.htm EX-31.2 10132
6 EX-32.1 mlys2022123110kex321.htm EX-32.1 5080
7 EX-32.2 mlys2022123110kex322.htm EX-32.2 5026
8 business11e.jpg GRAPHIC 662846
9 business12b.jpg GRAPHIC 270397
10 business13d.jpg GRAPHIC 552652
11 business1c.jpg GRAPHIC 196658
12 business2e.jpg GRAPHIC 537942
13 business3b.jpg GRAPHIC 671014
14 business4b.jpg GRAPHIC 386220
15 business5c.jpg GRAPHIC 1637794
16 business6b.jpg GRAPHIC 148220
17 business7e.jpg GRAPHIC 1449669
18 business8d.jpg GRAPHIC 393695
19 business9c.jpg GRAPHIC 631115
20 busniess10d.jpg GRAPHIC 616213
21 mineralyslogo.jpg GRAPHIC 34244
  Complete submission text file 0001933414-23-000012.txt   12469395
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41614 | Film No.: 23736185
SIC: 2834 Pharmaceutical Preparations